Nemaura Medical Inc.’s (NASDAQ: NMRD) CEO Dr. Faz Chowdhury Addresses Growing CGM Demand at H.C. Wainwright BioConnect Conference
NMRD CEO Dr. Faz Chowdhury presented at H.C. Wainwright BioConnect Conference held January 10-13, 2022Presentation revealed growing need for CGM devices, diabetes market estimated at $150 billionNMRD's sugarBEAT(R) devices measure glucose at the skin surface, non-invasive, easy to useNMRD recently commenced product shipments in lieu of an order for 5,000 CGM devices and 200,000 sensors to UK licensing partner MySugarWatch LimitedNMRD recently announced launch of…